Funds holding Fulcrum Therapeutics Inc
ISIN US3596161097 · United States
- Fund holders
- 152
- Of which ETFs
- 34 118 other funds
- Value held
- 80M $
- Share of capital
- 13.6 % of 76.3M shares on Jul 23, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Voya VACS Index Series SC Portfolio Voya VARIABLE PORTFOLIOS INC | 3,696 | 28.3K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Small Cap Growth Index Fund Fidelity Salem Street Trust | 3,643 | 27.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis U.S. Small Cap Equity Fund American Century ETF Trust | 3,621 | 30.3K $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Venerable Small Cap Index Fund Venerable Variable Insurance Trust | 3,507 | 26.9K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| VANGUARD RUSSELL 3000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 3,418 | 28.6K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| LVIP Dimensional U.S. Core Equity 2 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 3,143 | 24.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| VIP Extended Market Index Portfolio Variable Insurance Products Fund II | 3,092 | 23.7K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SA U.S. Small Company Fund SA FUNDS INVESTMENT TRUST | 3,048 | 23.4K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 3,042 | 25.5K $ | 0.03 % | 0.00 % | as of Feb 28, 2026 ↗ |
| VANGUARD RUSSELL 2000 GROWTH INDEX FUND VANGUARD SCOTTSDALE FUNDS | 3,032 | 25.4K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Dimensional US Core Equity 1 ETF Dimensional ETF Trust | 3,000 | 21.4K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| PHARMACEUTICALS ULTRASECTOR PROFUND ProFunds | 2,765 | 19.7K $ | 0.59 % | 0.00 % | as of Apr 30, 2026 ↗ |
| ProShares Ultra Russell2000 ProShares Trust | 2,667 | 22.3K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares UltraPro Russell2000 ProShares Trust | 2,660 | 22.3K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Longboard Fund NORTHERN LIGHTS FUND TRUST II | 2,653 | 22.2K $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 2,499 | 20.9K $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Small-Cap Equity Portfolio PACIFIC SELECT FUND | 2,462 | 18.9K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Morgan Stanley Pathway Small-Mid Cap Equity ETF MORGAN STANLEY PATHWAY FUNDS | 2,335 | 19.6K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| JNL/DFA U.S. Core Equity Fund JNL Series Trust | 2,262 | 17.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Dimensional US Vector Equity ETF Dimensional ETF Trust | 1,960 | 14K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| iShares Total U.S. Stock Market Index Fund BlackRock Funds | 1,951 | 13.9K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| ProShares Russell 2000 High Income ETF ProShares Trust | 1,866 | 15.6K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| BlackRock Advantage SMID Cap V.I. Fund BlackRock Variable Series Funds, Inc. | 1,812 | 13.9K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Nationwide Fundamental All Cap Equity Portfolio Nationwide Mutual Funds | 1,805 | 12.9K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| SmallCap Value Fund II Principal Funds, Inc | 1,767 | 12.6K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| EQ/Franklin Small Cap Value Managed Volatility Portfolio EQ Advisors Trust | 1,591 | 12.2K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Penn Series Small Cap Index Fund Penn Series Funds Inc | 1,400 | 10.7K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 1,233 | 10.3K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 1,165 | 8.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 1,152 | 8.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis U.S. Equity Fund American Century ETF Trust | 1,126 | 9.4K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Bridge Builder Small/Mid Cap Growth Fund Bridge Builder Trust | 941 | 7.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 912 | 7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| EQ/Morgan Stanley Small Cap Growth Portfolio EQ Advisors Trust | 822 | 6.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 800 | 6.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 675 | 4.8K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 500 | 3.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 353 | 2.5K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Wilshire 5000 Index Fund Wilshire Mutual Funds Inc | 295 | 2.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 218 | 1.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 200 | 1.5K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| iShares Core S&P Total U.S. Stock Market ETF iShares Trust | 200 | 1.5K $ | 0.00 % | as of Mar 31, 2026 ↗ | |
| SmallCap Growth Fund I Principal Funds, Inc | 167 | 1.2K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 151 | 1.2K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PD Small-Cap Growth Index Portfolio PACIFIC SELECT FUND | 145 | 1.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 109 | 777.2 $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 100 | 767 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 74 | 567.6 $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 60 | 460.2 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 44 | 368.7 $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 12 | 100.6 $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 11 | 84.4 $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF SPDR SERIES TRUST | 0.92 % | as of Mar 31, 2026 ↗ |
| PROFUND VP PHARMACEUTICALS ProFunds | 0.88 % | as of Mar 31, 2026 ↗ |
| Direxion Daily Pharmaceutical & Medical Bull 3X Shares Direxion Shares ETF Trust | 0.59 % | as of Apr 30, 2026 ↗ |
| PHARMACEUTICALS ULTRASECTOR PROFUND ProFunds | 0.59 % | as of Apr 30, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 0.41 % | as of Apr 30, 2026 ↗ |
| Simplify Health Care ETF Simplify Exchange Traded Funds | 0.38 % | as of Mar 31, 2026 ↗ |
| Invesco Dorsey Wright SmallCap Momentum ETF Invesco Exchange-Traded Fund Trust II | 0.28 % | as of Feb 28, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 0.10 % | as of Mar 31, 2026 ↗ |
| VANGUARD U.S. MOMENTUM FACTOR ETF VANGUARD WELLINGTON FUND | 0.08 % | as of Feb 28, 2026 ↗ |
| Franklin Small Cap Enhanced ETF Franklin Templeton ETF Trust | 0.07 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 152 | +12 | 10,410,521 | +18.7 % |
| 2026Q1 | 140 | +2 | 8,768,459 | +0.5 % |
| 2025Q4 | 138 | 0 | 8,721,489 | -7.4 % |
| 2025Q3 | 138 | +3 | 9,420,019 | -2.4 % |
| 2025Q2 | 135 | +2 | 9,650,230 | -9.2 % |
| 2025Q1 | 133 | -12 | 10,631,577 | -23.8 % |
| 2024Q4 | 145 | +59 | 13,949,005 | +26.1 % |
| 2024Q3 | 86 | +20 | 11,066,083 | +8.7 % |
| 2024Q2 | 66 | +8 | 10,182,368 | +6.4 % |
| 2024Q1 | 58 | +2 | 9,568,794 | +0.7 % |
| 2023Q4 | 56 | 9,503,669 |
Institutional managers
163 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 6,561,111 | 50.3M $ | as of Mar 31, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | 6,053,960 | 46.4M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 5,390,593 | 41.3M $ | as of Mar 31, 2026 |
| TCG Crossover Management, LLC | 5,250,000 | 40.3M $ | as of Mar 31, 2026 |
| BRAIDWELL LP | 3,134,922 | 24M $ | as of Mar 31, 2026 |
| Nantahala Capital Management, LLC | 3,050,040 | 23.4M $ | as of Mar 31, 2026 |
| Siren, L.L.C. | 2,350,000 | 18M $ | as of Mar 31, 2026 |
| First Turn Management, LLC | 2,256,109 | 17.3M $ | as of Mar 31, 2026 |
| Aberdeen Group plc | 2,211,953 | 17M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 2,074,855 | 15.9M $ | as of Mar 31, 2026 |
| GSK plc | 1,785,714 | 13.7M $ | as of Mar 31, 2026 |
| Balyasny Asset Management L.P. | 1,779,946 | 13.7M $ | as of Mar 31, 2026 |
| Jones Hill Capital LP | 1,771,926 | 13.6M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 1,623,281 | 12.5M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 1,549,851 | 11.9M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,486,542 | 11.4M $ | as of Mar 31, 2026 |
| Alyeska Investment Group, L.P. | 1,328,449 | 10.2M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 1,292,486 | 9.9M $ | as of Mar 31, 2026 |
| Assenagon Asset Management S.A. | 1,193,873 | 9.2M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 1,130,281 | 8.7M $ | as of Mar 31, 2026 |
| Vestal Point Capital, LP | 1,100,000 | 8.4M $ | as of Mar 31, 2026 |
| Ikarian Capital, LLC | 1,049,161 | 8M $ | as of Mar 31, 2026 |
| Qube Research & Technologies Ltd | 974,739 | 7.5M $ | as of Mar 31, 2026 |
| Connor, Clark & Lunn Investment Management Ltd. | 736,684 | 5.7M $ | as of Mar 31, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | 727,315 | 5.6K $ | as of Mar 31, 2026 |
Declared shareholders of Fulcrum Therapeutics Inc
There are 4 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| EcoR1 Capital, LLC and 2 others | 9.00 % | 6,000,000 | as of Jun 17, 2026 · SCHEDULE 13G |
| TANG CAPITAL MANAGEMENT, LLC and 5 others | 8.20 % | 5,451,800 | as of Jun 3, 2026 · SCHEDULE 13G |
| TCG Crossover GP II, LLC and 2 others | 7.90 % | 5,250,000 | as of Mar 31, 2026 · SCHEDULE 13G |
| Nantahala Capital Management, LLC and 2 others | 4.58 % | 3,050,040 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding Fulcrum Therapeutics Inc". https://titelia.com/en/stocks/fulcrum-therapeutics-inc-US3596161097